Is Emergent Biosolutions (EBS) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 01/06/21
Emergent BioSolutions and Mount Sinai Health System Announce Initiation of DOD-Funded Clinical Program to Evaluate COVID-19 Human Hyperimmune Globulin (COVID-HIG) Product Candidate for ProphylaxisGlobeNewsWire • 12/29/20
Emergent Biosolutions (EBS) Down 14.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 12/05/20
Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/06/20
Emergent Biosolutions (EBS) Stock Sinks As Market Gains: What You Should KnowZacks Investment Research • 10/29/20
Has Emergent Biosolutions (EBS) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 10/21/20
Emergent Biosolutions (EBS) Gains As Market Dips: What You Should KnowZacks Investment Research • 10/15/20
Emergent BioSolutions to Release Third Quarter 2020 Financial Results and Conduct Conference Call on November 5, 2020GlobeNewsWire • 10/15/20
Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Included in NIH-Sponsored Phase 3 Clinical Trial of Hyperimmune Intravenous Immunoglobulin to Treat COVID-19GlobeNewsWire • 10/08/20
Is Emergent Biosolutions (EBS) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 10/05/20